Literature DB >> 22009979

The use of bone morphogenetic protein 7 in fracture non-unions.

Sven O'hEireamhoin1, John F Quinlan, Kieran O Rourke.   

Abstract

OBJECTIVE: To assess the rate of clinical and radiological union with the use of bone morphogenetic protein 7 (BMP-7) in a range of fractures.
METHODS: This case series retrospectively reviews a series of 16 fracture non-unions in 13 patients. These patients were treated with the commercially available BMP-7. Time to radiological and clinical union was assessed by serial out-patient follow-up.
RESULTS: At nine months post-surgery in which BMP-7 was added, 12 of 16 non-unions had achieved clinical and radiographic union. Three patients required repeat grafting. The mean time to union was 5.1 ± 1.6 months after the application of BMP-7.
CONCLUSION: The use of the osteo-inductive agent, BMP-7 results in good clinical and radiological outcomes which are not restricted to tibial non-unions.
© 2011 Tianjin Hospital and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009979      PMCID: PMC6583434          DOI: 10.1111/j.1757-7861.2010.00119.x

Source DB:  PubMed          Journal:  Orthop Surg        ISSN: 1757-7853            Impact factor:   2.071


  3 in total

Review 1.  Clinical application of bone morphogenetic proteins for bone healing: a systematic review.

Authors:  Gopal Shankar Krishnakumar; Alice Roffi; Davide Reale; Elizaveta Kon; Giuseppe Filardo
Journal:  Int Orthop       Date:  2017-04-19       Impact factor: 3.075

2.  Osteogenic response to BMP-2 of hMSCs grown on apatite-coated scaffolds.

Authors:  Hillary E Davis; Erin M Case; Stephanie L Miller; Damian C Genetos; J Kent Leach
Journal:  Biotechnol Bioeng       Date:  2011-06-21       Impact factor: 4.530

Review 3.  Studies of bone morphogenetic protein-based surgical repair.

Authors:  Kevin W-H Lo; Bret D Ulery; Keshia M Ashe; Cato T Laurencin
Journal:  Adv Drug Deliv Rev       Date:  2012-04-02       Impact factor: 15.470

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.